OneAscent Financial Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-497
Closed -$268K – 298
2024
Q1
$268K Buy
497
+98
+25% +$53.6K 0.03% 309
2023
Q4
$221K Buy
+399
New +$187K 0.03% 327
2022
Q2
– Sell
-519
Closed -$284K – 236
2022
Q1
$284K Buy
519
+45
+9% +$23.7K 0.2% 92
2021
Q4
$312K Buy
474
+47
+11% +$29.5K 0.6% 71
2021
Q3
$266K Buy
+427
New +$287K 0.35% 65
2020
Q4
– Sell
-790
Closed -$311K – 151
2020
Q3
$311K Buy
+790
New +$292K 0.16% 134

Other funds holding IDXX

OneAscent Financial Services's IDXX Position: Q2 2024 in Review

OneAscent Financial Services sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 497 shares — an estimated $268K sold.

OneAscent Financial Services first reported a position in IDXX in Q3 2020 and held it in 6 quarters. The position peaked at $312K in Q4 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • OneAscent Financial Services reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • OneAscent Financial Services sold 497 Idexx Laboratories shares in Q2 2024, an estimated $268K.
  • OneAscent Financial Services first reported a position in Idexx Laboratories in Q3 2020 and held it in 6 quarters.
  • OneAscent Financial Services's Idexx Laboratories position peaked at $312K in Q4 2021.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on OneAscent Financial Services's 13F filing for Q2 2024, filed 17 Jul 2024.